Response to the letter to the editor on "an indirect treatment comparison of the efficacy of patisiran and tafamidis for the treatment of hereditary transthyretin-mediated amyloidosis with polyneuropathy".

Lin, Hollis; Agarwal, Sonalee; Betts, Marissa; Fahrbach, Kyle; Chitnis, Madhura; Polydefkis, Michael

Lin, Hollis; Agarwal, Sonalee; Betts, Marissa; Fahrbach, Kyle; Chitnis, Madhura; Polydefkis, Michael.

Afiliación

Lin H; Alnylam Pharmaceuticals , Cambridge , MA , USA.
Agarwal S; Alnylam Pharmaceuticals , Cambridge , MA , USA.
Betts M; Evidera , Waltham , MA , USA.
Fahrbach K; Evidera , Waltham , MA , USA.
Chitnis M; Evidera , Waltham , MA , USA.
Polydefkis M; Department of Neurology, Johns Hopkins University , Baltimore , MD , USA.

Expert Opin Pharmacother ; 20(12): 1529-1530, 2019 08.

Article en En | MEDLINE | ID: mdl-31124741

Asunto(s)

Neuropatías Amiloides Familiares; Polineuropatías; Benzoxazoles; Humanos; Prealbúmina; ARN Interferente Pequeño

Palabras clave

Transthyretin amyloid polyneuropathy; indirect treatment comparison

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Polineuropatías / Neuropatías Amiloides Familiares Límite: Humans Idioma: En Revista: Expert Opin Pharmacother Asunto de la revista: FARMACOLOGIA Año: 2019 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google